Cost saving by project based prescription of generic ACE inhibitors;Kostenreduktion durch projektgestützte verschreibung von ACE-hemmer generika

Wiener Klinische Wochenschrift

Volumn 115, Issue 1-2, 2003, Pages 23-28

  Wolzt, Michael ^a   Ohrenberger, Gerald ^b   Reichardt, Berthold ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^c Burgenlandische Gebietskrankenkasse   (Austria)

Author keywords

Drug utilisation; Generic drugs; Health care quality; Patient compliance; Pharmacoeconomics

Indexed keywords

CAPTOPRIL; CARDIOVASCULAR AGENT; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; GENERIC DRUG; IMIDAPRIL; LISINOPRIL; QUINAPRIL; RAMIPRIL; SPIRAPRIL;

ARTICLE; AUSTRIA; COST CONTROL; DRUG COST; HEALTH INSURANCE; HOSPITAL DISCHARGE; HUMAN; PRESCRIPTION;

EID: 0037473835     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03040268     Document Type: Article

References (15)

1. Hauptverband der Sozialversicherungsträger, www.soz-vers. at/hvb/statistik/ESV_Statistik/Heilmittel_a.htm (Zugriff am 24. 6. 2002)
2. Datenbank der Sozialversicherungsträger PEGASUS
3. McManus P, Birkett DJ, Dudley J, Stevens A (2001) Impact of the minimum pricing policy and introduction of brand (generic) substitution into the pharmaceutical benefits scheme in Australia. Pharmacoepidemiol Drug Saf 10: 295-300
4. Mott DA, Cline RR (2002) Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med Care 40: 662-674
5. Roberts SJ, Bateman DN, Smith JM (1997) Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines. Br J Gen Pract 47: 13-18
6. Wie geht's, Mitteilungsblatt der Burgenländischen Gebietskrankenkasse (2001)
7. Dusing R (2001) Adverse events, compliance, and changes in therapy. Curr Hypertens Rep 3: 488-492
8. Balazovjech I, Hnilica P Jr (1993) Compliance with antihypertensive treatment in consultation rooms for hypertensive patients. J Hum Hypertens 7: 581-583
9. Ren XS, Kazis LE, Lee A, Zhang H, Miller DR (2002) Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther 27: 47-56
10. Wilson RP, Hatcher J, Barton S, Walley T (1999) Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fund-holders and non-fundholders. Br J Gen Pract 49: 431-435
11. Gill PS, Makela M, Vermeulen KM, Freemantle N, Ryan G, Bond C, Thorsen T, Haaijer-Ruskamp FM (1999) Changing doctor prescribing behaviour. Pharm World Sci 21: 158-167
12. Dezii CM (2000) A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care 9 [Suppl 91: 2-6
13. Mallion JM, Schmitt D (2001) Patient compliance in the treatment of arterial hypertension. J Hypertens 19: 2281-2283
14. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E (2001) Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 323: 142-146
15. Jokisalo E, Kumpusalo E, Enlund H, Takala J (2001) Patients' perceived problems with hypertension and attitudes towards medical treatment. J Hum Hypertens 15: 755-761